All In Biotech

Drug Trial Radar · NCT02648204

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes

Last checked: Nov 20, 2026Latest source record: Oct 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,201 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,201

Actual

Start

Jan 6, 2016

Primary completion

Apr 10, 2017

Study completion May 19, 2017

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Jan 6, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes.

Conditions

  • Diabetes
  • Diabetes Mellitus, Type 2

Interventions

  • semaglutideDrug

    Administered subcutaneously (s.c., under the skin) once-weekly.

  • DulaglutideDrug

    Administered subcutaneously (s.c., under the skin) once-weekly.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in HbA1cTime frame: Week 0, week 40

Locations

209 sites in 17 countries. Site status is shown where the registry gives one.

  • Novo Nordisk Investigational Site

    Tuscumbia, Alabama

  • Novo Nordisk Investigational Site

    Chandler, Arizona

  • Novo Nordisk Investigational Site

    Phoenix, Arizona

  • Novo Nordisk Investigational Site

    Phoenix, Arizona

  • Novo Nordisk Investigational Site

    Anaheim, California

  • Novo Nordisk Investigational Site

    Buena Park, California

  • Novo Nordisk Investigational Site

    Carlsbad, California

  • Novo Nordisk Investigational Site

    Concord, California

  • Novo Nordisk Investigational Site

    Huntington Park, California

  • Novo Nordisk Investigational Site

    Lincoln, California

  • Novo Nordisk Investigational Site

    Los Angeles, California

  • Novo Nordisk Investigational Site

    Montclair, California

  • Novo Nordisk Investigational Site

    Poway, California

  • Novo Nordisk Investigational Site

    Riverside, California

  • Novo Nordisk Investigational Site

    San Diego, California

  • Novo Nordisk Investigational Site

    Tustin, California

  • Novo Nordisk Investigational Site

    Van Nuys, California

  • Novo Nordisk Investigational Site

    Denver, Colorado

  • Novo Nordisk Investigational Site

    Norwalk, Connecticut

  • Novo Nordisk Investigational Site

    Clearwater, Florida

  • Novo Nordisk Investigational Site

    Clearwater, Florida

  • Novo Nordisk Investigational Site

    Coral Gables, Florida

  • Novo Nordisk Investigational Site

    Edgewater, Florida

  • Novo Nordisk Investigational Site

    Fort Lauderdale, Florida

  • Novo Nordisk Investigational Site

    Kissimmee, Florida

  • Novo Nordisk Investigational Site

    Miami, Florida

  • Novo Nordisk Investigational Site

    Orlando, Florida

  • Novo Nordisk Investigational Site

    Orlando, Florida

  • Novo Nordisk Investigational Site

    Pembroke Pines, Florida

  • Novo Nordisk Investigational Site

    Port Orange, Florida

  • Novo Nordisk Investigational Site

    Tampa, Florida

  • Novo Nordisk Investigational Site

    Tampa, Florida

  • Novo Nordisk Investigational Site

    Adairsville, Georgia

  • Novo Nordisk Investigational Site

    Atlanta, Georgia

  • Novo Nordisk Investigational Site

    Bainbridge, Georgia

  • Novo Nordisk Investigational Site

    Conyers, Georgia

  • Novo Nordisk Investigational Site

    Marietta, Georgia

  • Novo Nordisk Investigational Site

    Marietta, Georgia

  • Novo Nordisk Investigational Site

    Suwanee, Georgia

  • Novo Nordisk Investigational Site

    Meridian, Idaho

Showing 40 of 209 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.